Brind.

Sight Sciences Executive Stock Sales Disclosed via SEC Filing

2 reports, 1 independent Updated Oct 8
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Sight Sciences, Inc. disclosed executive stock sales through a legal filing with the SEC. The company's EVP, Brenton Taylor, sold 2,988 shares of Sight Sciences on October 2nd. The average selling price was $8.85 per share, totaling $26,443.80. Following the transaction, Taylor remained an owner of 261,990 shares.

From tickerreport.com

Why it matters

Some supportBrind's analysis of the reports

The disclosure concerns the sale of company stock by a senior executive. This information is made public through required filings with the SEC. The company also receives analyst ratings and coverage from Citigroup.

From tickerreport.com

Who's involved

  • SIGHT SCIENCES, INC.Company subject to SEC disclosure requirements regarding executive stock sales.
  • CitigroupProvides analyst ratings and coverage on Sight Sciences, Inc. stock.
  • SECRegulatory body receiving required financial disclosures from publicly traded companies.

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
1 more outlet ran the same wire story